ATR INHIBITORS IN COMBINATION WITH RADIATION AND TEMOZOLOMIDE INCREASE CELL DEATH OF PATIENT-DERIVED GLIOBLASTOMA CELLS

被引:0
|
作者
Lozinski, Mathew [1 ,2 ]
Bowden, Nikola [3 ]
Fay, Michael [2 ,4 ]
Graves, Moira [1 ,5 ]
Day, Bryan [6 ]
Stringer, Brett [7 ]
Tooney, Paul [1 ,2 ]
机构
[1] Univ Newcastle, Callaghan, Australia
[2] Mark Hughes Fdn Ctr Brain Canc Res, Callaghan, Australia
[3] Hunter Med Res Inst, Drug Repurposing & Med Res Program, New Lambton Hts, Australia
[4] GenesisCare, Newcastle, Australia
[5] Hunter Med Res Inst, Drug Repurposing & Med Res Program, Callaghan, Australia
[6] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia
[7] Griffith Univ, Griffith Inst Drug Discovery, Nathan, Australia
关键词
D O I
10.1093/neuonc/noae165.0458
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
NOAE165.04
引用
收藏
页数:1
相关论文
共 50 条
  • [1] ATR INHIBITORS INCREASE THE ANTI-PROLIFERATIVE EFFECTS OF STANDARD TREATMENT ON PATIENT-DERIVED GLIOBLASTOMA CELLS
    Lozinski, M.
    Bowden, N.
    Graves, M.
    Day, B.
    Stringer, B.
    Fay, M.
    Tooney, P.
    NEURO-ONCOLOGY, 2024, 26 : V43 - V43
  • [2] Synergistic combination of perphenazine and temozolomide suppresses patient-derived glioblastoma tumorspheres
    Hong, Jun Pyo
    Choi, Ran Joo
    Shim, Jin-Kyoung
    Kim, Kibyeong
    Kim, Ryong Nam
    Cho, Hyejoung
    Kim, Seo Jin
    Kim, Sohyun
    Kim, Nam Hwa
    Park, Hun Ho
    Moon, Ju Hyung
    Kim, Eui Hyun
    Teo, Wan-Yee
    Chung, Seungsoo
    Chang, Jong Hee
    Kang, Seok-Gu
    NEURO-ONCOLOGY, 2024,
  • [3] ATR INHIBITION ENHANCES CELL DEATH AND INDUCES IMMUNE-RELATED GENE EXPRESSION IN COMBINATION WITH STANDARD TREATMENT IN PATIENT-DERIVED GLIOBLASTOMA CELLS
    Lozinski, M.
    Bowden, N.
    Graves, M.
    Fay, M.
    Day, B.
    Stringer, B.
    Tooney, P.
    NEURO-ONCOLOGY, 2023, 25
  • [4] COMBINATION OF IN VITRO TUMOR TREATING FIELDS AND TEMOZOLOMIDE DECREASE PROLIFERATION IN PATIENT-DERIVED GLIOBLASTOMA CELL LINES
    Michelhaugh, Sharon K.
    Kiousis, Sam
    Mittal, Sandeep
    NEURO-ONCOLOGY, 2017, 19 : 76 - 77
  • [5] Transcriptomic Profiling of DNA Damage Response in Patient-Derived Glioblastoma Cells before and after Radiation and Temozolomide Treatment
    Lozinski, Mathew
    Bowden, Nikola A.
    Graves, Moira C.
    Fay, Michael
    Day, Bryan W.
    Stringer, Brett W.
    Tooney, Paul A.
    CELLS, 2022, 11 (07)
  • [6] Alternating Radiation Fractionations Overcome Radioresistance in Patient-Derived Glioblastoma Cells
    Nassour, L.
    Honan, B.
    Stackhouse, C.
    Peacock, J.
    Willey, C. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E76 - E76
  • [7] MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell Lines
    Malacrida, Alessio
    Di Domizio, Alessandro
    Bentivegna, Angela
    Cislaghi, Giacomo
    Messuti, Eleonora
    Tabano, Silvia Maria
    Giussani, Carlo
    Zuliani, Valentina
    Rivara, Mirko
    Nicolini, Gabriella
    BIOLOGY-BASEL, 2022, 11 (01):
  • [8] Effect of treating glioblastoma with a cytokine inhibitor, ibudilast, in combination with temozolomide on survival in a patient-derived xenograft model.
    McDonald, Kerrie Leanne
    Ha, Wendy
    Sevim, Hatice
    Matsuda, Kazuko
    Khasraw, Mustafa
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [9] The combination therapy using tyrosine kinase receptors inhibitors and repurposed drugs to target patient-derived glioblastoma stem cells
    Kucinska, Malgorzata
    Pospieszna, Julia
    Tang, Jing
    Lisiak, Natalia
    Toton, Ewa
    Rubis, Blazej
    Murias, Marek
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 176
  • [10] Genomic Exploration of Distinct Molecular Phenotypes Steering Temozolomide Resistance Development in Patient-Derived Glioblastoma Cells
    Fabro, Federica
    Kers, Trisha V.
    Feller, Kate J.
    Beerens, Cecile
    Ntafoulis, Ioannis
    Idbaih, Ahmed
    Verreault, Maite
    Connor, Kate
    Biswas, Archita
    Salvucci, Manuela
    Prehn, Jochen H. M.
    Byrne, Annette T.
    O'Farrell, Alice C.
    Lambrechts, Diether
    Dilcan, Gonca
    Lodi, Francesca
    Arijs, Ingrid
    Kremer, Andreas
    Yen, Romain Tching Chi
    Chien, Miao-Ping
    Lamfers, Martine L. M.
    Leenstra, Sieger
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (21)